133 related articles for article (PubMed ID: 11558477)
1. Immunosuppressant substitutes in liver transplantation.
Ascher NL
Lancet; 2001 Feb; 357(9256):571-2. PubMed ID: 11558477
[No Abstract] [Full Text] [Related]
2. Conversion to combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy for renal dysfunction in liver transplant patients: never too late?
Beckebaum S; Cicinnati VR
Dig Dis Sci; 2011 Jan; 56(1):4-6. PubMed ID: 21049289
[No Abstract] [Full Text] [Related]
3. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.
McKane W; Kanganas C; Preston R; Cairns T; Hakim N; Palmer A; Taube D
Transplant Proc; 2001; 33(1-2):1224-5. PubMed ID: 11267268
[No Abstract] [Full Text] [Related]
4. Steroid sparing strategies in renal transplantation.
Grinyó JM
Nephrol Dial Transplant; 2005 Oct; 20(10):2028-31. PubMed ID: 16105871
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
6. [Toward an evidence-based immunosuppression].
Pascual J
Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
[No Abstract] [Full Text] [Related]
7. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
8. Sirolimus to replace calcineurin inhibitors? Too early yet.
Cravedi P; Ruggenenti P; Remuzzi G
Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
[No Abstract] [Full Text] [Related]
9. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction.
Koch RO; Graziadei IW; Schulz F; Nachbaur K; Königsrainer A; Margreiter R; Vogel W
Transpl Int; 2004 Oct; 17(9):518-24. PubMed ID: 15365603
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus: not so sparing in the Spare-the-Nephron trial.
Shamseddin MK; Gupta A
Kidney Int; 2011 Jun; 79(12):1379; author reply 1379-80. PubMed ID: 21625260
[No Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy.
Manfro RC; Vedolin L; Cantarelli M; Oppitz P; Antunes AC; Rieder CR
Transpl Infect Dis; 2009 Apr; 11(2):189-90. PubMed ID: 19210690
[TBL] [Abstract][Full Text] [Related]
12. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
Thervet E
Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
[No Abstract] [Full Text] [Related]
13. Diarrhea in a post-renal transplant child: questions.
Wiley JR; Shivaram P; Resnick JM; Fish DL; Park RW; Haws RM
Pediatr Nephrol; 2015 Apr; 30(4):589-90, 591-3. PubMed ID: 24165966
[No Abstract] [Full Text] [Related]
14. MYSS: should we alter clinical practice?
Maes B; Vanrenterghem Y
Lancet; 2004 Dec 4-10; 364(9450):2016-7; author reply 2017-8. PubMed ID: 15582052
[No Abstract] [Full Text] [Related]
15. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
Raimondo ML; Dagher L; Papatheodoridis GV; Rolando N; Patch DW; Davidson BR; Rolles K; Burroughs AK
Transplantation; 2003 Jan; 75(2):186-90. PubMed ID: 12548120
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil as induction therapy after liver transplantation.
McDiarmid SV
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
[No Abstract] [Full Text] [Related]
17. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: single-center experience.
Garcia CE; Ribeiro HB; Garcia RL; Copstein JL; Padilla JM; Santos TE; Amaral DD; Silva AO; D'Albuquerque LA
Transplant Proc; 2003 May; 35(3):1131-2. PubMed ID: 12947887
[No Abstract] [Full Text] [Related]
19. Mycophenolate mofetil: a decade of clinical experience.
Danovitch GM
Transplantation; 2005 Oct; 80(2 Suppl):S272-4. PubMed ID: 16251860
[No Abstract] [Full Text] [Related]
20. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Rerolle JP; Szelag JC; Le Meur Y
Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
